CryoLife to cash in on Bard buyout of Medafor

October 8, 2013 by Brad Perriello

CryoLife says it's in line for a $15 million payout due to its stake in Medafor, which C.R. Bard bought last week for some $280 million.

CryoLife to cash in on Bard buyout of Medafor

CryoLife Inc. (NYSE:CRY) said it's in line for a $15.1 million payout from the C.R. Bard (NYSE:BCR) acquisition of Minnesota-based Medafor for up to $280 million.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp